TR200003688T1 - Glutation'un absorbsıyonu'nun arttırılması ve etkilerinin güçlendirilmesi için kompozisyon - Google Patents
Glutation'un absorbsıyonu'nun arttırılması ve etkilerinin güçlendirilmesi için kompozisyonInfo
- Publication number
- TR200003688T1 TR200003688T1 TR2000/03688T TR200003688T TR200003688T1 TR 200003688 T1 TR200003688 T1 TR 200003688T1 TR 2000/03688 T TR2000/03688 T TR 2000/03688T TR 200003688 T TR200003688 T TR 200003688T TR 200003688 T1 TR200003688 T1 TR 200003688T1
- Authority
- TR
- Turkey
- Prior art keywords
- glutation
- composition
- strengthen
- absorption
- effects
- Prior art date
Links
- RWSXRVCMGQZWBV-WDSKDSINSA-N glutathione Chemical compound OC(=O)[C@@H](N)CCC(=O)N[C@@H](CS)C(=O)NCC(O)=O RWSXRVCMGQZWBV-WDSKDSINSA-N 0.000 title abstract 5
- 238000010521 absorption reaction Methods 0.000 title 1
- 240000004808 Saccharomyces cerevisiae Species 0.000 abstract 2
- 235000015872 dietary supplement Nutrition 0.000 abstract 2
- 239000004480 active ingredient Substances 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 235000005911 diet Nutrition 0.000 abstract 1
- 230000000378 dietary effect Effects 0.000 abstract 1
- 239000003814 drug Substances 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/205—Amine addition salts of organic acids; Inner quaternary ammonium salts, e.g. betaine, carnitine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/06—Fungi, e.g. yeasts
- A61K36/062—Ascomycota
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/06—Tripeptides
- A61K38/063—Glutathione
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/16—Drugs for disorders of the alimentary tract or the digestive system for liver or gallbladder disorders, e.g. hepatoprotective agents, cholagogues, litholytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Mycology (AREA)
- Gastroenterology & Hepatology (AREA)
- Heart & Thoracic Surgery (AREA)
- Immunology (AREA)
- Urology & Nephrology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Cardiology (AREA)
- Microbiology (AREA)
- Alternative & Traditional Medicine (AREA)
- Biotechnology (AREA)
- Botany (AREA)
- Medical Informatics (AREA)
- Biomedical Technology (AREA)
- Neurosurgery (AREA)
- Neurology (AREA)
- Vascular Medicine (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
Glutation'un absorbsiyonunun arttirilmasinda ve etkilerinin güçlendirilmesinde yararli olan, kullanicinin durumuna bagli olarak bir diyet takviyesi seklinde, bir diyet güçlendiricisi olarak ya da gerçek bir ilaç seklinde alinabilen, aktif maddeler olarak: (a) propionil L-karnitin'i ya da bunun farmakolojik olarak uygun olan bir tuzunu; (b) glutation'u ya da glutation içeren bir mayayi; (c) eger bilesik glutation içeriyor ise glutation'suz bir mayayi içermesiyle karakterize olan bir kompozisyon açiklanmaktadir.
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IT1999RM000230A IT1306130B1 (it) | 1999-04-16 | 1999-04-16 | Composizione comprendente una carnitina e glutatione, atta adaumentare l'assorbimento del glutatione sinergizzandone gli effetti. |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| TR200003688T1 true TR200003688T1 (tr) | 2001-06-21 |
Family
ID=11406677
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| TR2000/03688T TR200003688T1 (tr) | 1999-04-16 | 2000-04-07 | Glutation'un absorbsıyonu'nun arttırılması ve etkilerinin güçlendirilmesi için kompozisyon |
Country Status (25)
| Country | Link |
|---|---|
| US (1) | US6306392B1 (tr) |
| EP (1) | EP1087762B1 (tr) |
| JP (1) | JP2002542191A (tr) |
| KR (1) | KR20010071467A (tr) |
| CN (1) | CN1300214A (tr) |
| AR (1) | AR033325A1 (tr) |
| AT (1) | ATE282409T1 (tr) |
| AU (1) | AU774191B2 (tr) |
| BR (1) | BR0006045A (tr) |
| CA (1) | CA2334919C (tr) |
| DE (1) | DE60015893T2 (tr) |
| EE (1) | EE200000732A (tr) |
| ES (1) | ES2232443T3 (tr) |
| HU (1) | HU229272B1 (tr) |
| IL (1) | IL139851A0 (tr) |
| IS (1) | IS5740A (tr) |
| IT (1) | IT1306130B1 (tr) |
| NO (1) | NO20006285L (tr) |
| NZ (1) | NZ509276A (tr) |
| PL (1) | PL213130B1 (tr) |
| PT (1) | PT1087762E (tr) |
| SK (1) | SK18852000A3 (tr) |
| TN (1) | TNSN00077A1 (tr) |
| TR (1) | TR200003688T1 (tr) |
| WO (1) | WO2000062773A1 (tr) |
Families Citing this family (23)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IT1306147B1 (it) * | 1999-05-28 | 2001-05-30 | Biosalts Srl | Derivati di principi attivi ad attivita' terapeutica e/o nutrizionalee composizioni atte alla somministrazione orale contenenti tali |
| IT1306722B1 (it) * | 1999-10-08 | 2001-10-02 | Sigma Tau Healthscience Spa | Composizione per la prevenzione e/o il trattamento di disfunzionicircolatorie, comprendente derivati della l-carnitina ed estratti di |
| IT1316998B1 (it) * | 2000-03-02 | 2003-05-26 | Sigma Tau Healthscience Spa | Composizione per la prevenzione e/o il trattamento degli effetticitotossici indotti dall'uso di agenti immunosoppressori. |
| IT1316997B1 (it) * | 2000-03-02 | 2003-05-26 | Sigma Tau Healthscience Spa | Composizione per la prevenzione e/o il trattamento di vasculopatie,che comprende propionil l-carnitina e coenzima q10. |
| KR100528720B1 (ko) * | 2002-08-29 | 2005-11-15 | 주식회사 메디넥스 | 중금속 제거용 특수 영양식품 |
| ITRM20020620A1 (it) * | 2002-12-13 | 2004-06-14 | Sigma Tau Ind Farmaceuti | Uso delle carnitine per la prevenzione e/o il trattamento dei disturbi causati dall'andropausa. |
| US20050232911A1 (en) * | 2004-04-19 | 2005-10-20 | Schreiber Brian D | Prevention and treatment of metabolic abnormalities associated with excess intramyocellular lipid |
| JP5785355B2 (ja) * | 2004-11-24 | 2015-09-30 | ヒルズ・ペット・ニュートリシャン・インコーポレーテッド | 動物における生体異物物質の肝臓クリアランスを改良する方法 |
| US20090176864A1 (en) * | 2004-11-24 | 2009-07-09 | Hill's Pet Nutrition, Inc. | Methods For Improving Hepatic and Immune Function In An Animal |
| US8252742B2 (en) | 2004-12-30 | 2012-08-28 | Hill's Pet Nutrition, Inc. | Methods for enhancing the quality of life of a senior animal |
| EP1830629A4 (en) | 2004-12-30 | 2008-08-27 | Hills Pet Nutrition Inc | METHODS FOR ENHANCING THE QUALITY OF LIFE OF AN ANIMAL AGE |
| AU2006219823A1 (en) | 2005-03-02 | 2006-09-08 | Metanomics Gmbh | Process for the production of fine chemicals |
| CN101287460B (zh) | 2005-08-17 | 2012-04-25 | 希尔氏宠物营养品公司 | 预防和治疗肾病的组合物 |
| JP4831540B2 (ja) * | 2005-08-26 | 2011-12-07 | 株式会社興人 | 経口催眠剤及び催眠性飲食物 |
| JP2009107962A (ja) * | 2007-10-29 | 2009-05-21 | Asahi Breweries Ltd | 酵母エキス含有組成物 |
| MX2011004666A (es) * | 2008-11-11 | 2011-05-31 | Sigma Tau Ind Farmaceuti | Compuesto util para tratar celulitis. |
| CN103535721B (zh) * | 2013-09-27 | 2016-04-06 | 美国东方生物技术（香港）有限公司 | 提高人体内谷胱甘肽浓度的组合物及其制备方法和应用 |
| CN103478718B (zh) * | 2013-09-27 | 2015-10-28 | 美国东方生物技术（香港）有限公司 | 提高人体内谷胱甘肽浓度的功能食品及其制备方法 |
| CN105054068A (zh) * | 2014-01-25 | 2015-11-18 | 北京凯因科技股份有限公司 | 一种酵母谷胱甘肽营养配制品 |
| IL261670B (en) * | 2018-09-06 | 2019-06-30 | Tudu Holdings Ltd | A preparation that includes magnesium and its uses |
| JP7478517B2 (ja) * | 2019-04-24 | 2024-05-07 | 三菱商事ライフサイエンス株式会社 | 脂質活性代謝改善組成物 |
| KR102559814B1 (ko) * | 2021-05-14 | 2023-07-26 | 가톨릭대학교 산학협력단 | 글루타치온을 유효성분으로 포함하는 신장질환 치료용 약학적 조성물 |
| KR102535328B1 (ko) * | 2022-10-18 | 2023-05-26 | 주식회사 청안오가닉스 | 흑후추 추출물을 함유하여 글루타치온의 체내 흡수율을 높인 건강기능 식품용 조성물 및 이의 제조방법 |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IT1283951B1 (it) * | 1996-03-15 | 1998-05-07 | Mendes Srl | Uso della acetil l-carnitina o dei suoi sali farmacologicamente accettabili per il trattamento terapeutico o la profilassi di |
| IT1283967B1 (it) * | 1996-03-29 | 1998-05-07 | Sigma Tau Ind Farmaceuti | Uso di l-carnitina o derivati della l-carnitina ed antiossidanti nella prevenzione e trattamento di patologie derivanti da danni ossidativi |
| IT1291113B1 (it) * | 1997-03-20 | 1998-12-29 | Sigma Tau Ind Farmaceuti | Composizione nutritiva terapeutica per soggetti affetti da diabete mellito |
-
1999
- 1999-04-16 IT IT1999RM000230A patent/IT1306130B1/it active
-
2000
- 2000-03-20 AR ARP000101237A patent/AR033325A1/es unknown
- 2000-04-07 KR KR1020007014145A patent/KR20010071467A/ko not_active Withdrawn
- 2000-04-07 BR BR0006045-3A patent/BR0006045A/pt not_active Application Discontinuation
- 2000-04-07 WO PCT/IT2000/000129 patent/WO2000062773A1/en not_active Ceased
- 2000-04-07 PT PT00922845T patent/PT1087762E/pt unknown
- 2000-04-07 TR TR2000/03688T patent/TR200003688T1/tr unknown
- 2000-04-07 JP JP2000611909A patent/JP2002542191A/ja active Pending
- 2000-04-07 CA CA002334919A patent/CA2334919C/en not_active Expired - Fee Related
- 2000-04-07 US US09/719,176 patent/US6306392B1/en not_active Expired - Lifetime
- 2000-04-07 ES ES00922845T patent/ES2232443T3/es not_active Expired - Lifetime
- 2000-04-07 CN CN00800592A patent/CN1300214A/zh active Pending
- 2000-04-07 IL IL13985100A patent/IL139851A0/xx unknown
- 2000-04-07 HU HU0102501A patent/HU229272B1/hu not_active IP Right Cessation
- 2000-04-07 EP EP00922845A patent/EP1087762B1/en not_active Expired - Lifetime
- 2000-04-07 SK SK1885-2000A patent/SK18852000A3/sk unknown
- 2000-04-07 NZ NZ509276A patent/NZ509276A/xx unknown
- 2000-04-07 EE EEP200000732A patent/EE200000732A/xx unknown
- 2000-04-07 DE DE60015893T patent/DE60015893T2/de not_active Expired - Lifetime
- 2000-04-07 PL PL344790A patent/PL213130B1/pl not_active IP Right Cessation
- 2000-04-07 AU AU43117/00A patent/AU774191B2/en not_active Ceased
- 2000-04-07 AT AT00922845T patent/ATE282409T1/de active
- 2000-04-13 TN TNTNSN00077A patent/TNSN00077A1/fr unknown
- 2000-11-28 IS IS5740A patent/IS5740A/is unknown
- 2000-12-11 NO NO20006285A patent/NO20006285L/no not_active Application Discontinuation
Also Published As
| Publication number | Publication date |
|---|---|
| JP2002542191A (ja) | 2002-12-10 |
| ES2232443T3 (es) | 2005-06-01 |
| EP1087762B1 (en) | 2004-11-17 |
| DE60015893T2 (de) | 2005-12-01 |
| NZ509276A (en) | 2002-09-27 |
| PL213130B1 (pl) | 2013-01-31 |
| HUP0102501A3 (en) | 2002-12-28 |
| HUP0102501A2 (hu) | 2001-11-28 |
| CA2334919A1 (en) | 2000-10-26 |
| AR033325A1 (es) | 2003-12-17 |
| PL344790A1 (en) | 2001-11-19 |
| NO20006285L (no) | 2001-02-12 |
| TNSN00077A1 (fr) | 2002-05-30 |
| HU229272B1 (en) | 2013-10-28 |
| AU774191B2 (en) | 2004-06-17 |
| IL139851A0 (en) | 2002-02-10 |
| DE60015893D1 (de) | 2004-12-23 |
| EP1087762A1 (en) | 2001-04-04 |
| PT1087762E (pt) | 2005-03-31 |
| IT1306130B1 (it) | 2001-05-30 |
| NO20006285D0 (no) | 2000-12-11 |
| AU4311700A (en) | 2000-11-02 |
| SK18852000A3 (sk) | 2001-06-11 |
| WO2000062773A1 (en) | 2000-10-26 |
| EE200000732A (et) | 2002-06-17 |
| IS5740A (is) | 2000-11-28 |
| KR20010071467A (ko) | 2001-07-28 |
| CN1300214A (zh) | 2001-06-20 |
| ITRM990230A1 (it) | 2000-10-16 |
| US6306392B1 (en) | 2001-10-23 |
| ATE282409T1 (de) | 2004-12-15 |
| BR0006045A (pt) | 2001-03-13 |
| CA2334919C (en) | 2009-02-24 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| TR200003688T1 (tr) | Glutation'un absorbsıyonu'nun arttırılması ve etkilerinin güçlendirilmesi için kompozisyon | |
| MXPA04001231A (es) | Composiciones topicas para aplicar y no enjuagar que contiene derivados seleccionados del acido pantotenico. | |
| DK0796082T3 (da) | Orale sammensætninger indeholdende stabiliserede tinforbindelser | |
| GB0105772D0 (en) | Use | |
| CA2307667A1 (en) | Improved antiperspirant actives and formulations made therefrom | |
| EP1283054A4 (en) | MEDICAMENTS FOR TREATING THE COMPLICATIONS OF DIABETES AND NEUROPATHIES AND USE THEREOF | |
| ES2194452T3 (es) | Composiciones antitranspirantes que contienen 1,2-hexanodiol. | |
| BR9406514A (pt) | Composições terapeuticas de nadh e nadh estáveis que podem ser ingeridas e absorvidas | |
| ES2181501T3 (es) | Composicion cosmetica. | |
| PT1091740E (pt) | Preparacoes aquosas semi-solidas para administracao oral de toltrazuril-sulfona | |
| EP0712630A3 (fr) | Composition orale pour la prévention des allergies solaires à base d'un caroténoide, d'un tocophérol, d'acide ascorbique et de sélénium | |
| AU629445B2 (en) | Improvements in or relating to topical compositions containing 1 alpha 25-dihydroxycholecalciferol | |
| PT912167E (pt) | Granulos de derivados de hexa-hidropirazina administraveis por via oral | |
| TR200101344T2 (tr) | Propionil L-karnitinden ve bir flavonoid'den oluşan antioksidan bileşim | |
| KR970032819A (ko) | 미백화장료 조성물 | |
| CA2294482A1 (en) | Treatment of aging skin | |
| WO2002011740A3 (en) | 'slow release' pharmaceutical compositions comprising lithium carbonate | |
| ID27755A (id) | Komposisi parfum | |
| TR199701617T1 (tr) | Çiftliklerde üretilen baliklarda görülen parazitlerle mücadelede kullanilacak bir ajan. | |
| DE60219462D1 (de) | Verdickte wässrige zusammensetzungen | |
| JPS5562013A (en) | Aqueous poultice comprising transcutaneous absorbable anti-inflammatory agent | |
| ES2029337T3 (es) | Dentrifico con indicador de tiempo de cepillado. | |
| DE60231997D1 (de) | Orale pharmazeutische formulierung mit aktivkohle und ihre verwendung | |
| ATE368383T1 (de) | Gewürzkrautzubereitung | |
| AU7028798A (en) | Use of 2-methylthiazolidine-2,4-dicarboxylic acid as mucolytic agent |